The Spanish cyclist Enric Masof the Movistar Teamit will run anymore in the remainder of season 2025 because of a thrombophlebitis in the left leg that made him leave the past Francia Touras confirmed on Tuesday his team.
The Balearic corridor had to leave the 'Grande Boucle', in which he was not shining too much, in stage 18 after crowning the Col Du Glandon because of some pain in the left knee. Days later, the Movistar Team pointed out that the first medical tests indicated “the suspicion of phlebitis that causes strong pain in the left leg, preventing him from moving the articulation normally.”
«The pain in my leg prevented me from pedaling when I forced. After the suspicion of the diagnosis, it was successful to get off the tour and remedy as soon as possible in order to reach the next appointments in the best conditions, ”said Enric Mas.
However, this will not be possible after the new medical tests to which it was subjected and that have ended in “a thrombophlebitis in the left leg, of possible post-traumatic origin.” “This diagnosis requires a specific treatment based on rest and the absence of intense physical activity, which makes it impossible to participate in competitions during the rest of the season,” added the Movistar Team.
The Eusebio Unzué set stressed that “the medical and technical team will continue to carry out a narrow monitoring of its evolution, with the aim of guaranteeing a complete recovery” of the Balearic cyclist, which will not be able to be in the cycling return to Spain that starts at the end of this month.
Movistar Team statement on Enric Mas
After the latest medical consultations and the explorations made as a result of its abandonment in the past Tour de France, the Balearic has been diagnosed with thrombophlebitis in the left leg, of possible post-traumatic origin.
This diagnosis requires a specific treatment based on rest and the absence of intense physical activity, which makes it impossible for competitions during the rest of the season.
The medical and technical team will continue to carry out a narrow monitoring of its evolution, with the aim of guaranteeing a complete recovery.
